We value the trust placed in us by our clients. Every complaint, query or grievance received is acknowledged, reviewed and resolved in a timely and transparent manner while ensuring compliance with applicable SEBI regulations and internal grievance redressal procedures.
Our objective is to provide fair, ethical and professional investor support throughout your engagement with TredAce.
While submitting a complaint, kindly provide your full name, registered mobile number, registered email address, details of the subscribed research service, complete description of the grievance and supporting documents (if any).
Every genuine grievance received by TredAce is acknowledged promptly. We endeavor to resolve complaints within 21 working days from the date of receipt, depending upon the nature and complexity of the matter.
| Designation | Contact Details | Working Hours |
|---|---|---|
| Customer Support |
Email : yohandoka7865@gmail.com Mobile : +91 96647 65786 |
Monday – Friday 10:00 AM – 6:00 PM |
| Compliance Officer |
Email : yohandoka7865@gmail.com Mobile : +91 96647 65786 |
Monday – Friday 10:00 AM – 6:00 PM |
| Principal Officer |
Mr. Yohan Imran Doka Email : yohandoka7865@gmail.com Mobile : +91 96647 65786 |
Monday – Friday 10:00 AM – 6:00 PM |
If your grievance remains unresolved or you are not satisfied with our response, you may approach the following regulatory grievance redressal mechanisms:
All complaints, communications, investigation records, correspondence, resolutions and supporting documents are maintained by TredAce in accordance with applicable SEBI regulations and statutory record retention requirements.
TredAce is a SEBI Registered Research Analyst (Registration No. INH000028529). Research services are provided in accordance with the SEBI (Research Analysts) Regulations and other applicable laws. Investments in securities markets are subject to market risks. The Research Analyst does not guarantee profits, assured returns, or risk-free outcomes. Complaints arising solely due to market fluctuations, investment losses, or trading decisions shall not be treated as deficiencies in research services.